bioRxiv Science⌕ Search

Biology subjects

Luque, Y.

Publications and source records attributed to Luque, Y..

2 recordsLinked to original sources

Enhanced Kidney Targeting and Distribution of Tubuloids During Normothermic Perfusion

Tubuloids have become a promising tool for kidney disease model and regeneration, although their ability for integration and regeneration in vivo is not well documented. Here we establish, characterize and compare human tubuloids using two optimized protocols, which added a prior isolation of tubular cells (Crude tubuloids) and proximal tubular cells (F4 tubuloids). Secondly, using this protocol, healthy rat-derived tubuloids were established. Finally, we compared two strategies to deliver GFP tubuloids in a kidney host: 1) subcapsular/intracortical injection and 2) tubuloid infusion during normothermic preservation in a rat transplantation model and a human discarded kidney. F4 tubuloids achieved a more differentiation state compared to Crude tubuloids. When analyzing tubuloid delivery to the kidney, normothermic perfusion was more efficient compared to in vivo injection, observing fully-developed tubules in the host parenchyma after 1 week and 1 month. Normothermic perfusion also successfully delivered kidney tubuloids to a discarded human kidney for transplantation. These results suggest that tubuloids administered during normothermic perfusion represent a potential strategy to enhance the translatability of kidney regenerative therapies to the clinical practice to condition kidney grafts and to treat kidney diseases.

bioengineering↗

Protective role of podocytic IL-15/STAT5 pathway in experimental focal and segmental glomerulosclerosis

During glomerular diseases, podocyte-specific pathways can modulate the intensity of the lesions and prognosis. The therapeutic targeting of these pathways could thus improve the management and prognosis of chronic kidney diseases. The Janus Kinase/ Signal Transducer and Activator of Transcription (JAK/STAT) pathway, classically described in immune cells, has been recently described in intrinsic kidney cells. Here, we show, for the first time, that STAT5 is activated in human podocytes in focal segmental glomerulosclerosis (FSGS). Additionally, Stat5 podocyte-specific inactivation aggravates the functional and structural alterations in a mouse model of FSGS. This could be due, at least in part, to an inhibition of the autophagic flux. Finally, Interleukin 15 (IL-15), a classical activator of STAT5 in immune cells, increases STAT5 phosphorylation in human podocytes and its administration alleviates glomerular injury in vivo by maintaining the autophagy flux in podocytes. In conclusion, activating podocytic STAT5 with commercially available IL-15 represents a new therapeutic avenue with the potential for FSGS.

pathology↗